Published in Drug Alcohol Depend on May 27, 2015
Clinical guidelines for the use of chronic opioid therapy in chronic noncancer pain. J Pain (2009) 9.36
Opiates, cocaine and alcohol combinations in accidental drug overdose deaths in New York City, 1990-98. Addiction (2003) 4.25
Heroin-related deaths in New South Wales, 1992: toxicological findings and circumstances. Med J Aust (1996) 2.36
Trends in prescription drug abuse and dependence, co-occurrence with other substance use disorders, and treatment utilization: results from two national surveys. Addict Behav (2008) 2.01
Evaluating the impact of methadone maintenance programmes on mortality due to overdose and aids in a cohort of heroin users in Spain. Addiction (2005) 1.96
Polydrug abuse: a review of opioid and benzodiazepine combination use. Drug Alcohol Depend (2012) 1.85
Diversion and abuse of buprenorphine: findings from national surveys of treatment patients and physicians. Drug Alcohol Depend (2011) 1.45
Diversion of buprenorphine/naloxone coformulated tablets in a region with high prescribing prevalence. J Addict Dis (2009) 1.42
American Society of Interventional Pain Physicians (ASIPP) guidelines for responsible opioid prescribing in chronic non-cancer pain: Part 2--guidance. Pain Physician (2012) 1.42
Six deaths linked to concomitant use of buprenorphine and benzodiazepines. Addiction (1998) 1.32
A critical review of the causes of death among post-mortem toxicological investigations: analysis of 34 buprenorphine-associated and 35 methadone-associated deaths. Addiction (2004) 1.26
Characterization of methadone overdose: clinical considerations and the scientific evidence. Ther Drug Monit (2002) 1.21
Detection times for urinary ethyl glucuronide and ethyl sulfate in heavy drinkers during alcohol detoxification. Alcohol Alcohol (2008) 1.13
Opioid maintenance treatment as a harm reduction tool for opioid-dependent individuals in New York City: the need to expand access to buprenorphine/naloxone in marginalized populations. J Addict Dis (2012) 1.08
Effects of acute oral naltrexone on the subjective and physiological effects of oral D-amphetamine and smoked cocaine in cocaine abusers. Neuropsychopharmacology (2013) 0.97
Prospective comparative assessment of buprenorphine overdose with heroin and methadone: clinical characteristics and response to antidotal treatment. J Subst Abuse Treat (2010) 0.96
Risks, management, and monitoring of combination opioid, benzodiazepines, and/or alcohol use. Postgrad Med (2013) 0.95
Urine drug testing: current recommendations and best practices. Pain Physician (2012) 0.93
The subjective, reinforcing, and analgesic effects of oxycodone in patients with chronic, non-malignant pain who are maintained on sublingual buprenorphine/naloxone. Neuropsychopharmacology (2010) 0.88
Testing positive for methadone and either a tricyclic antidepressant or a benzodiazepine is associated with an accidental overdose death: analysis of medical examiner data. Acad Emerg Med (2006) 0.87
Death attributed to methadone. Pharmacopsychiatry (2001) 0.86
Heroin-related deaths in south-western Sydney. Med J Aust (1997) 0.86
Hepatitis C infection in non-treatment-seeking heroin users: the burden of cocaine injection. Am J Addict (2013) 0.85
Is this urine really negative? A systematic review of tampering methods in urine drug screening and testing. J Subst Abuse Treat (2007) 0.84
Abuse potential of intranasal buprenorphine versus buprenorphine/naloxone in buprenorphine-maintained heroin users. Addict Biol (2014) 0.81
Diversity in causes and characteristics of drug-induced deaths in an urban setting. Scand J Public Health (2013) 0.79
Testing for drug abuse. Lancet (1996) 0.78
Urine labeling with orally applied marker substances in drug substitution therapy. Clin Chem Lab Med (2004) 0.78
Clinical use of polyethylene glycols as marker substances and determination in urine by liquid chromatography. J Chromatogr B Analyt Technol Biomed Life Sci (2003) 0.77